| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.5 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |